These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34557121)

  • 1. Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine.
    Fitzgerald I; O'Dwyer S; Brooks M; Sahm L; Crowley E; Ní Dhubhlaing C
    Front Psychiatry; 2021; 12():730769. PubMed ID: 34557121
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Praharaj SK; Jana AK; Goyal N; Sinha VK
    Br J Clin Pharmacol; 2011 Mar; 71(3):377-82. PubMed ID: 21284696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis.
    Correll CU; Højlund M; Graham C; Todtenkopf MS; McDonnell D; Simmons A
    Int J Neuropsychopharmacol; 2023 Jul; 26(7):451-464. PubMed ID: 37326421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice.
    Shamshoum H; Medak KD; McKie GL; Jeromson S; Hahn MK; Wright DC
    Biomed Pharmacother; 2023 Dec; 168():115671. PubMed ID: 37839107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain.
    Corrao MM; Nelson LA
    CNS Drugs; 2022 Jun; 36(6):605-616. PubMed ID: 35644903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.
    Ma X; Maimaitirexiati T; Zhang R; Gui X; Zhang W; Xu G; Hu G
    Int J Psychiatry Clin Pract; 2014 Oct; 18(4):229-42. PubMed ID: 25152019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?
    Faden J; Serdenes R; Citrome L
    Expert Rev Neurother; 2022 May; 22(5):365-376. PubMed ID: 35354374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Zhornitsky S; Brunelle S; Stip E
    Drug Saf; 2012 Oct; 35(10):819-36. PubMed ID: 22967188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining samidorphan with olanzapine to mitigate weight gain as a side effect in schizophrenia treatment.
    Grywińska WB; Głowacka A
    Postep Psychiatr Neurol; 2023 Sep; 32(3):128-137. PubMed ID: 38034507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia.
    Liang L; Ren X; Xu J; Ma Y; Xue Y; Zhuang T; Zhang G
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment.
    Lian J; Huang XF; Pai N; Deng C
    PLoS One; 2014; 9(8):e104160. PubMed ID: 25084453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.
    Baptista T; Rangel N; Fernández V; Carrizo E; El Fakih Y; Uzcátegui E; Galeazzi T; Gutiérrez MA; Servigna M; Dávila A; Uzcátegui M; Serrano A; Connell L; Beaulieu S; de Baptista EA
    Schizophr Res; 2007 Jul; 93(1-3):99-108. PubMed ID: 17490862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
    Hoffmann VP; Case M; Jacobson JG
    J Clin Psychiatry; 2012 Feb; 73(2):216-23. PubMed ID: 21672497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future.
    Citrome L; McEvoy JP; Todtenkopf MS; McDonnell D; Weiden PJ
    Neuropsychiatr Dis Treat; 2019; 15():2559-2569. PubMed ID: 31564881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New discoveries for an old drug: a review of recent olanzapine research.
    Meftah AM; Deckler E; Citrome L; Kantrowitz JT
    Postgrad Med; 2020 Jan; 132(1):80-90. PubMed ID: 31813311
    [No Abstract]   [Full Text] [Related]  

  • 19. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
    Lian J; Deng C
    Pharmacol Biochem Behav; 2020 Apr; 191():172878. PubMed ID: 32112786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and berberine prevent olanzapine-induced weight gain in rats.
    Hu Y; Young AJ; Ehli EA; Nowotny D; Davies PS; Droke EA; Soundy TJ; Davies GE
    PLoS One; 2014; 9(3):e93310. PubMed ID: 24667776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.